Member Info for POSTI

Well I’ve just bought a hefty chunk on the back of that RNS . Wait till it’s widely publicised what we are into ;-)
Gla

Not sure of why the sudden drop in SP. Maybe it was the wording of future revenues in the RNS. I have personally been on the sidelines on this since the beginning having missed 70p & ever since thought I've missed the train . Will definitely be buying a large chunk tomorrow hopefully we get a drop & that will be the bottom. The saying never look a gift horse comes to mind ,can see these @ £18 in 12 months ,first mover advantage & US markets beckoning. I feel NCYT & SNG go hand in hand .

Take a look at RR Share price , they recently had a heavily discounted RI , Tui share price is going in the same direction, £2.50 sounds about right to me after the 29th when the takers of the offer sell on open market , just my opinion

1.07 E . Is that some sort of joke price for the RI . Hate to say it When these start trading on the 20th Jan the sp will be no more than 2.30 . Just look at RR as a prime example

Was this mentioned in the scsw? If not any ideas what was NAPS etc ?
Cheers P

What happened to the SP today ? No RNS out , this was looking healthy last week .

Adamstallone you are not alone , I went in on the 1.98 spike , can’t believe I’ve halved my money while the rest of the general market has shot up . Tempted to average down . Just need a good RNS & we should be back to £1.50 , either way Ime not taking a hit on this , bottom draw as you say :-l

Must be Massive the order from India ....

Far from it , let the city Digest what the company has said & telling them what’s in the pipeline , Higher Highs imho

Great RNS & just how I love them out of the Blue .
£60 million investment that’s not to be sniffed at its got Confidence written all over it . Loads of Irons in the fire ready to mature in 2021. Investors long term will hugely be rewarded .
GLA

Why were the Rights priced so LOW 32p ? & what price was the actual stock on cut of date ?

Seems the management don’t have too much faith or they know the shorters are going to run rampant on this ,Hence the 32p price .

This company was blown out of proportion glad I sold in the 30s this price action is not good for your health. They dangled the carrot with the India deal , that’s History now

People keep banging on about this dropping to 32p dream on ! Ok have to admit a lot of stocks drop to the RI price but these are 2 bob Aim stocks , ROLLS is a blue chip ftse 100 company .
Anyone short on this is only going to see GHOSTS & PHANTOMS no pun intended Haunting them ;-)

My £20k buy on Friday seems like it was perfect timing , didn't expect this today like anyone else . This is the Base now , onwards & upwards from here , not in any rush shares tucked away in the isa .

Just bought 28723 be lucky !

Really don’t think it’s us , it’s wishful thinking, but this is what the sun article is referring too imho .

HTTPS://www.google.co.uk/amp/s/www.yorkshirepost.co.uk/business/consumer/avacta-set-momentous-milestones-it-prepares-launch-covid-19-test-2985152%3famp

Unvrkw , I really thought I would be able to get in lower , how wrong was I my ego took over & even buying in at 57 , I thought I would get in lower hence only took 25000 . There will no doubt be many like me especially at NCYT , how many chances did we get to get on that train , hopefully ODX follows it .

I held over a 100k from around 27p , lost my bottle when it dropped from 70p to 34p. What a difference that would have made too me now ! Riding it from 57 with only a quarter of my initial holdings doubled my money. Ime out before the next set of numbers is released,idealey £1.50 is reached before then my initial exit price , no point being too greedy from past life changing positions (OUCH)
Gla

RNS in the morning, obviously Lilly have to let the Rabbit out the hat first !
:)

Looks like we’re Barking up the same tree!

Current landscape for COVID-19 neutralising antibodies
Neutralising antibody treatment is seen as a promising form of therapy for COVID-19 and there are a number of groups, alongside Hemogenyx, looking to develop treatments. Regeneron Pharmaceuticals is using its own mouse model system, VelocImmune®, to isolate virus-neutralising antibodies. In June 2020, the company began testing of a treatment, known as REGN-COV2, in Phase 1 trials in both hospitalised and non-hospitalised COVID-19 patients. REGN-COV2 consists of two neutralising Abs which both non-competitively target the S protein. Their rationale of using a ‘****tail’ treatment compared to a single therapeutic approach is to maintain efficacy in the scenario that the virus mutates to escape treatment.
In May 2020, Amgen and Adaptive Biotechnologies partnered to develop a neutralising Ab based on the identification of tens of thousands of naturally occurrin